Author Guidelines

The International Journal of Pharmaceuticals and Health Care Research (IJPHR) welcomes original and scientifically sound manuscripts in pharmaceutical sciences, healthcare research and related interdisciplinary areas within the journal's scope.

1. Submission of Manuscripts

Authors should submit manuscripts through the official IJPHR online submission system available through the journal's Submissions page.

The corresponding author is responsible for ensuring that all listed authors have reviewed and approved the manuscript and have agreed to its submission.

Routine manuscript submission should be completed through the online journal system. Email may be used for editorial enquiries or technical assistance.

2. Originality

Submitted manuscripts must represent original scholarly work, must not have been published previously and must not be simultaneously under consideration by another journal.

3. Types of Manuscripts

IJPHR considers the following article categories:

Original Research Articles
Review Articles
Systematic Reviews and Meta-Analyses
Short Communications
Technical Notes
Case Reports or Case Series where scientifically appropriate
Other scholarly article types considered suitable by the editorial office

4. Title Page

The title page should contain the complete manuscript title, full names of all authors, institutional affiliations and corresponding-author information.

The title should be concise, specific and scientifically informative.

5. Abstract

The abstract should accurately summarize the objectives, methods, principal results and conclusions of the study. Original research manuscripts should use a structured abstract where appropriate.

6. Keywords

Authors should normally provide three to six relevant keywords suitable for indexing and discovery.

7. Original Research Article Structure

Original Research Articles should normally contain:

Title Page → Abstract → Keywords → Introduction → Materials and Methods → Results → Discussion → Conclusion → Acknowledgements → Author Contributions → Funding → Conflict of Interest → Data Availability → Ethical Approval where applicable → References.

8. Introduction

The Introduction should explain the scientific background, identify the relevant research gap and clearly state the objective or hypothesis of the study.

9. Materials and Methods

Methods should be described with sufficient detail to permit scientific evaluation and, where appropriate, reproducibility.

Previously established methods should be appropriately referenced. New or substantially modified procedures should be adequately described.

10. Statistical Analysis

Authors should identify the statistical methods and software used where applicable. Statistical analyses should be appropriate to the study design and reported sufficiently for scientific evaluation.

11. Results

Results should be presented clearly and objectively. Tables and figures should complement rather than unnecessarily duplicate information in the text.

12. Discussion

The Discussion should interpret the findings in relation to the research objectives and relevant literature. Important limitations and implications of the study should be addressed.

13. Conclusion

The conclusion should be supported by the findings and should avoid claims extending beyond the evidence presented.

14. Human Research Ethics

Research involving human participants must comply with applicable institutional and national ethical requirements. Approval from an appropriate ethics committee or institutional review board should be obtained where required.

The manuscript should identify the approving committee and approval number where applicable. Informed consent must be obtained when required.

15. Animal Research Ethics

Research involving animals must comply with applicable ethical and animal-welfare requirements. Relevant ethical approval details should be reported in the manuscript where required.

16. Patient and Participant Confidentiality

Authors must protect participant confidentiality. Information capable of identifying an individual should not be published without appropriate authorization or consent where required.

17. Reporting Guidelines

Authors should use recognized reporting guidelines appropriate to the study design where applicable. These may include CONSORT for randomized trials, PRISMA for systematic reviews and meta-analyses, STROBE for observational research, CARE for case reports, STARD for diagnostic accuracy studies and ARRIVE for animal research.

18. Clinical Trial Registration

Clinical trials should comply with applicable registration, regulatory and ethical requirements. Where prospective registration is required, the trial registration number and registry should be reported in the manuscript.

19. Authorship

Authorship should represent substantial scholarly contribution to the work. All listed authors should participate sufficiently in the research and manuscript to accept responsibility for their contribution.

Administrative position, academic seniority, routine supervision or provision of funding alone does not justify authorship.

Individuals who contributed to the work but do not satisfy authorship requirements should be acknowledged appropriately.

20. Author Contributions

Authors are encouraged to provide a concise statement describing individual contributions to the study and manuscript.

21. Conflict of Interest

Authors must disclose financial, professional, institutional or personal relationships that could reasonably be perceived as influencing the work.

Where no competing interests exist, this should be stated clearly.

22. Funding

All sources of financial or material support should be disclosed. Where no external funding was received, authors should provide an appropriate statement.

23. Data Availability

Authors should include an appropriate Data Availability Statement where relevant, describing whether supporting research data are available and how they may be accessed.

24. Artificial Intelligence and AI-Assisted Technologies

Authors should disclose material use of generative artificial intelligence or AI-assisted technologies where such tools have contributed substantially to manuscript preparation, data processing, analysis, coding, image generation or another substantive component of the work.

Artificial intelligence systems cannot be listed as authors. Human authors remain responsible for the accuracy, originality, integrity, citations and scientific validity of submitted content.

25. Tables

Tables should be numbered consecutively according to their first citation in the manuscript. Each table should contain a concise and informative title and should be supplied in an editable format.

26. Figures

Figures should be numbered consecutively and supplied at sufficient resolution for publication. Each figure should contain an appropriate legend.

Authors are responsible for obtaining permission where previously published copyrighted material is reproduced.

27. Units and Terminology

SI units should be used where applicable. Generic names of medicines are preferred. Proprietary names may be included where scientifically necessary.

28. Reference Style

IJPHR follows the Harvard author-date referencing style.

In-text references should normally contain the author's surname and year of publication, for example (Sharma, 2024). Multiple references should be presented consistently according to the Harvard author-date system.

The reference list should be arranged alphabetically according to the surname of the first author. Authors are responsible for the completeness and accuracy of all references.

Where a DOI is available, it should be included in the reference.

29. Research Integrity

IJPHR does not tolerate plagiarism, fabricated or falsified data, duplicate publication, inappropriate image manipulation, citation manipulation, inappropriate authorship or other forms of research misconduct.

Submitted manuscripts may be evaluated using similarity-detection software.

30. Supplementary Material

Datasets, questionnaires, research instruments, supplementary tables, figures or other supporting files may be submitted where they contribute materially to understanding the research.

31. Proofs

The corresponding author should carefully review publication proofs. Proof-stage corrections should normally be limited to production errors and necessary factual corrections.

32. Editorial Enquiries

For editorial or technical enquiries, authors may contact the journal office at editorijphrjournal@gmail.com.

33. Journal Details

Journal: International Journal of Pharmaceuticals and Health Care Research (IJPHR)
eISSN: 2306-6091
Publisher: Futuristic Publications
Publication Frequency: Quarterly
Licence: CC BY 4.0

Author Guidelines